Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Expanded use of Photofrin approved by FDA

Jan. 4, 1999

Ajinomoto prepares potent, water-soluble combretastatin analogues

Dec. 30, 1998

IND filed by Cell Pathways for new SAAND; lead compound Prevatac enters clinic for sixth indication

Dec. 30, 1998

Water-soluble anticancer compounds available for licensing from NIH

Dec. 30, 1998

Several NDAs up for review by FDA oncologic advisory committee in January

Dec. 30, 1998

Grant to help Faulding and collaborators develop innovative prostate cancer treatment

Dec. 29, 1998

Vion pursues prodrugs of 3-AP with superior biological, pharmaceutical properties

Dec. 29, 1998

Resveratrol shown to bind to and cleave DNA

Dec. 29, 1998

U.S. clinical trials of SU-6668 slated for early 1999

Dec. 29, 1998

Isis obtains antisense cancer rights from Genzyme Molecular Oncology

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...